Many people with diabetes have the earliest stage of diabetic retinopathy, called mild nonproliferative diabetic retinopathy (NPDR), without even knowing it, according to the American Academy of ...
In a study published July 26 online in the journal Diabetes, physician-researchers from University Hospitals Rainbow Babies and Children's Hospital and Case Western Reserve University School of ...
A newly identified protein may hold the key to preventing diabetic blindness. Researchers discovered that LRG1 triggers the ...
The drug Eylea can be used to treat the early stages of diabetic retinopathy, reducing the chances of serious vision loss. Share on Pinterest Experts say people with diabetes should have an eye exam ...
Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.
In a paper published by the research team of Ali Hafezi-Moghadam, MD, PhD at the Brigham and Women’s Hospital (BWH), a founding member of Mass General Brigham, authors introduced a biodegradable ...
Diabetic retinopathy involves damage to the eye’s retina due to high blood sugar levels in the body. It is a common complication of diabetes, affecting millions of people with both type 1 and type 2 ...
In a study published online by JAMA Ophthalmology, Gwyneth Rees, Ph.D., of the University of Melbourne, Australia, and colleagues examined the association between severity of diabetic retinopathy and ...
Chronically high or variable blood sugar levels from diabetes can damage blood vessels in the retina, the light-sensitive tissue at the back of the eye. This can cause the eye disease diabetic ...
The Hearty Soul on MSN
Doctors can spot diabetes and cancer in your eyes. Are you missing the signs?
The human eye is often described metaphorically as the "window to the soul," but in clinical medicine, it is more accurately viewed as a non-invasive window into the human body's circulatory and ...
Weight loss medications Mounjaro and Zepbound, which contain the active ingredient tirzepatide, may lower the risk of diabetic retinopathy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results